2019
DOI: 10.2147/ceor.s179892
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: PurposePrevious Japanese studies have not compared health-related quality of life (HRQoL), work productivity and activity impairment, health care resource utilization (HRU), and costs in inflammatory bowel disease (IBD) patients with non-IBD controls, leading to insufficient evidence regarding IBD’s true burden. The aim of this study was to examine the impact of IBD on patient-reported outcomes and costs among Japanese adults (≥18 years).Patients and methodsThis retrospective cross-sectional study used data fr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
19
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(22 citation statements)
references
References 29 publications
(59 reference statements)
1
19
2
Order By: Relevance
“…The number of hospital admissions per month in the present study was slightly lower than 0.28 admissions per month reported by Yamabe et al [ 31 ], who retrospectively analyzed data from the 2012–2014 Japan National Health and Wellness Survey. UC treatment costs as well as its contribution to total healthcare costs (72.3%) were highest in the sixth LoT, probably due to increased usage of biologics.…”
Section: Discussioncontrasting
confidence: 80%
See 2 more Smart Citations
“…The number of hospital admissions per month in the present study was slightly lower than 0.28 admissions per month reported by Yamabe et al [ 31 ], who retrospectively analyzed data from the 2012–2014 Japan National Health and Wellness Survey. UC treatment costs as well as its contribution to total healthcare costs (72.3%) were highest in the sixth LoT, probably due to increased usage of biologics.…”
Section: Discussioncontrasting
confidence: 80%
“…UC treatment costs as well as its contribution to total healthcare costs (72.3%) were highest in the sixth LoT, probably due to increased usage of biologics. Total annual direct costs estimated in the present study (JPY 656,928 and JPY 526,932 for treatment non-naïve and naïve patients, respectively) were substantially less than the cost reported by Yamabe et al (JPY 2,135,095) [ 31 ], who used self-reported survey responses for cost estimation, which may have a potentially unverified resource utilization and inflated cost reporting. The present study also shows that most of the UC patients were of working age (30–50 years old), and around 30% of them had a dependent insurance status.…”
Section: Discussioncontrasting
confidence: 74%
See 1 more Smart Citation
“…Costs were found to be highest in North America ($20 074), mostly driven by presenteeism 90 . Only one study reported on absenteeism and presenteeism in Asia, and no studies were done in Oceania 89 . Studies in Europe estimated a broader range of productivity costs, also reporting on early retirement or disability, loss of unpaid time and caregiver absenteeism.…”
Section: Resultsmentioning
confidence: 99%
“…troublesome symptoms, such as abdominal pain, diarrhea, hematochezia, fever, perianal lesions, weight loss, and fatigue, which can impact markedly on patient quality of life (QoL) [1][2][3][4][5]. In addition to enteric complications (eg, stricture, abscess, fistula, hemorrhage), CD may also result in extraintestinal inflammatory complications in the joints, skin, eyes, mouth, and other organ systems [1][2][3].…”
mentioning
confidence: 99%